SCHEMBL172344

SCHEMBL172344

CC[C@H](C)NC(C)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.66
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 4/20 0.47
CYP3A4 P08684 3/20 0.47
CHRM2 P08172 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CHRM1 P11229 1/20 0.47
SMPD1 P17405 1/20 0.47
DRD1 P21728 1/20 0.47
TBXA2R P21731 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRM1 P35372 1/20 0.47
DRD3 P35462 1/20 0.47
CASR P41180 1/20 0.47
HTR2B P41595 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954149 0.87 SIGMAR1 (0.60) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL19954192 0.83 SIGMAR1 (0.61) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL19563117 0.83 SIGMAR1 (0.61) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL29216796 0.83 SIGMAR1 (0.46) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL2233513 0.83 RAB9A (0.46) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL9768694 0.83 SIGMAR1 (0.55) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL28552790 0.83 SIGMAR1 (0.55) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL28552787 0.83 SIGMAR1 (0.55) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL8437895 0.81 SIGMAR1 (0.61) SIGMAR1MEN1KMT2ALMNACYP3A4
SCHEMBL283979 0.81 SIGMAR1 (0.61) SIGMAR1MEN1KMT2ALMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255738-B1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO NEUROCRINE BIOSCIENCES INC (US) 2012-03-07 EP disclosed